SAN.PA vs. JNJ
Compare and contrast key facts about Sanofi (SAN.PA) and Johnson & Johnson (JNJ).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SAN.PA or JNJ.
Correlation
The correlation between SAN.PA and JNJ is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
SAN.PA vs. JNJ - Performance Comparison
Loading data...
Key characteristics
SAN.PA:
0.18
JNJ:
0.34
SAN.PA:
0.23
JNJ:
0.62
SAN.PA:
1.03
JNJ:
1.09
SAN.PA:
0.06
JNJ:
0.41
SAN.PA:
0.17
JNJ:
1.10
SAN.PA:
7.73%
JNJ:
6.37%
SAN.PA:
20.68%
JNJ:
18.66%
SAN.PA:
-50.84%
JNJ:
-52.60%
SAN.PA:
-15.23%
JNJ:
-9.41%
Fundamentals
SAN.PA:
€113.50B
JNJ:
$374.53B
SAN.PA:
€4.99
JNJ:
$8.99
SAN.PA:
18.62
JNJ:
17.15
SAN.PA:
0.83
JNJ:
1.06
SAN.PA:
2.51
JNJ:
4.19
SAN.PA:
1.51
JNJ:
4.80
SAN.PA:
€43.77B
JNJ:
$89.33B
SAN.PA:
€31.14B
JNJ:
$61.01B
SAN.PA:
€10.09B
JNJ:
$34.70B
Returns By Period
In the year-to-date period, SAN.PA achieves a -0.87% return, which is significantly lower than JNJ's 7.49% return. Over the past 10 years, SAN.PA has underperformed JNJ with an annualized return of 4.07%, while JNJ has yielded a comparatively higher 7.32% annualized return.
SAN.PA
-0.87%
4.35%
-2.95%
2.59%
3.98%
4.07%
JNJ
7.49%
3.72%
0.79%
6.18%
3.55%
7.32%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SAN.PA vs. JNJ — Risk-Adjusted Performance Rank
SAN.PA
JNJ
SAN.PA vs. JNJ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sanofi (SAN.PA) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
SAN.PA vs. JNJ - Dividend Comparison
SAN.PA's dividend yield for the trailing twelve months is around 4.05%, more than JNJ's 3.22% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SAN.PA Sanofi | 4.05% | 4.01% | 3.97% | 3.71% | 3.61% | 4.00% | 3.43% | 4.00% | 4.12% | 3.81% | 3.63% | 3.70% |
JNJ Johnson & Johnson | 3.22% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% |
Drawdowns
SAN.PA vs. JNJ - Drawdown Comparison
The maximum SAN.PA drawdown since its inception was -50.84%, roughly equal to the maximum JNJ drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for SAN.PA and JNJ. For additional features, visit the drawdowns tool.
Loading data...
Volatility
SAN.PA vs. JNJ - Volatility Comparison
Sanofi (SAN.PA) has a higher volatility of 10.79% compared to Johnson & Johnson (JNJ) at 5.26%. This indicates that SAN.PA's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
SAN.PA vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Sanofi and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SAN.PA vs. JNJ - Profitability Comparison
SAN.PA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Sanofi reported a gross profit of 7.72B and revenue of 10.61B. Therefore, the gross margin over that period was 72.8%.
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported a gross profit of 14.54B and revenue of 21.89B. Therefore, the gross margin over that period was 66.4%.
SAN.PA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Sanofi reported an operating income of 2.29B and revenue of 10.61B, resulting in an operating margin of 21.5%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported an operating income of 6.30B and revenue of 21.89B, resulting in an operating margin of 28.8%.
SAN.PA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Sanofi reported a net income of 1.87B and revenue of 10.61B, resulting in a net margin of 17.7%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported a net income of 11.00B and revenue of 21.89B, resulting in a net margin of 50.2%.